[1]
Ranpura, V. et al. 2010. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials. Acta Oncologica. 49, 3 (Jan. 2010), 287–297. DOI:https://doi.org/10.3109/02841860903524396.